Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection (MK-5172-096)
Clinical trial NCT03111108 · COMPLETED
Trial details
- NCT number
- NCT03111108
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-20
- Primary completion
- 2018-10-15
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.